- List
- By Topic
- On Map
- Search Details

stem cell autoimmune disease
Need help? See RSS Feeds
Choose a feed type:

stem cell autoimmune disease (234 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT00742300 | Unknown † | Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
All | 18 Years to 60 Years (Adult) | NCT00742300 | CT-0198 | ASTRAD | January 1998 | August 27, 2008 | November 24, 2008 |
|
|||||
2 | NCT00849745 | Terminated | Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
4 | All | 18 Years to 69 Years (Adult, Older Adult) | NCT00849745 | Pro00010324 | January 2003 | July 2015 | July 2015 | February 24, 2009 | June 23, 2016 |
|
|||
3 | NCT00010335 | Completed | Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
6 | All | 2 Years to 18 Years (Child, Adult) | NCT00010335 | 1353.00 FHCRC-1353.00 199/15575 |
November 2000 | July 2010 | May 2011 | February 2, 2001 | March 6, 2015 |
|
|||
4 | NCT01540292 | Unknown † | Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
20 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01540292 | TJT1123 | March 2012 | June 2016 | June 2017 | February 28, 2012 | January 21, 2013 |
|
|||
5 | NCT00716066 | Recruiting | Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
40 | All | up to 70 Years (Child, Adult, Older Adult) | NCT00716066 | 2260.00 NCI-2010-00403 P30CA015704 |
June 2008 | March 31, 2020 | December 1, 2021 | July 16, 2008 | December 18, 2018 |
|
|||
6 | NCT01099930 | Completed | Autologous Stem Cell Transplant for Multiple Sclerosis |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
24 | All | 18 Years to 50 Years (Adult) | NCT01099930 | 200037401H | MS/BMT | August 2001 | November 2012 | June 2016 | April 8, 2010 | September 28, 2016 |
|
||
7 | NCT01673789 | Unknown † | Stem Cell Educator Therapy in Alopecia Areata |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry / Other |
|
|
30 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01673789 | 2012-TH01 | August 2012 | July 2013 | July 2013 | August 28, 2012 | August 28, 2012 |
|
|||
8 | NCT02516124 | Completed | EBMT ADWP Prospective Non Interventional Study : AutoHSCT in SSc Patients |
|
|
Observational |
|
Other |
|
|
82 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02516124 | NISSC | December 2012 | January 2018 | March 2018 | August 5, 2015 | May 1, 2018 |
|
||||
9 | NCT02264405 | Unknown † | Autologous SCT for Progressive Systemic Sclerosis: a Prospective NIS Study |
|
|
Observational |
|
Other |
|
|
50 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02264405 | EBMT-8410015 | NISSC | December 2012 | December 2015 | December 2017 | October 15, 2014 | October 20, 2014 |
|
|||
10 | NCT03444805 | Not yet recruiting | EBMT ADWP Prospective Non-interventional Study: Post-AHSCT Management in SSC Patients (NISSC-2) |
|
|
Observational |
|
Other |
|
|
60 | All | 18 Years and older (Adult, Older Adult) | NCT03444805 | ADWP 8410025 | NISSC-2 | June 1, 2018 | December 31, 2019 | March 30, 2020 | February 23, 2018 | May 1, 2018 |
|
|||
11 | NCT01322789 | Unknown † | Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
10 | All | 12 Years to 35 Years (Child, Adult) | NCT01322789 | HCFMRPUSP 2 CNPQ 552266/2005-1 |
September 2008 | November 2015 | December 2015 | March 25, 2011 | March 25, 2011 |
|
|||
12 | NCT02644759 | Completed | Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
100 | All | 8 Years to 55 Years (Child, Adult) | NCT02644759 | SCA-DM1 | February 2014 | August 2017 | May 2018 | January 1, 2016 | June 6, 2018 |
|
|||
13 | NCT00273364 | Active, not recruiting | Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
110 | All | 18 Years to 55 Years (Adult) | NCT00273364 | DI MS.Randomized2004 | November 16, 2005 | February 2018 | December 2018 | January 9, 2006 | July 16, 2018 |
|
|||
14 | NCT02282514 | Active, not recruiting | Stem Cell Transplantation for Stiff Person Syndrome (SPS) |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
23 | All | 18 Years to 60 Years (Adult) | NCT02282514 | DIAD.SPS.2014 | SPS | October 2014 | October 2020 | October 2021 | November 4, 2014 | January 31, 2019 |
|
||
15 | NCT02824393 | Completed | Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria |
|
|
Interventional |
Early Phase 1 |
|
Other |
|
|
10 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02824393 | TUBITAK-1001-215S612 | March 3, 2017 | May 15, 2018 | July 15, 2018 | July 6, 2016 | July 18, 2018 |
|
|||
16 | NCT01996228 | Recruiting | Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry / Other |
|
|
20 | All | 6 Years to 14 Years (Child) | NCT01996228 | 2013-0002 | November 2013 | October 2019 | October 2019 | November 27, 2013 | February 5, 2019 |
|
|||
17 | NCT00278538 | Active, not recruiting | Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
33 | All | 15 Years to 60 Years (Child, Adult) | NCT00278538 | DI SLE.Auto2003 | September 23, 2005 | February 2018 | December 2018 | January 18, 2006 | July 16, 2018 |
|
|||
18 | NCT00006055 | Unknown † | Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases |
|
|
Interventional |
Not Applicable |
|
Other |
|
10 | All | 1 Year to 55 Years (Child, Adult) | NCT00006055 | 199/15105 UMN-MT-1996-15 UMN-MT-9615 |
March 2000 | July 6, 2000 | June 24, 2005 |
|
||||||
19 | NCT01341899 | Completed | Efficacy and Safety Study of Autologous Hematopoietic Stem Cell Transplantation to Treat New Onset Type 1 Diabetes |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
50 | All | 8 Years to 35 Years (Child, Adult) | NCT01341899 | ZKX07012 | June 2006 | December 2012 | December 2015 | April 26, 2011 | November 1, 2016 |
|
|||
20 | NCT00114530 | Completed Has Results |
Scleroderma: Cyclophosphamide or Transplantation (SCOT) |
|
|
Interventional |
Phase 2 Phase 3 |
|
NIH |
|
|
75 | All | 18 Years to 69 Years (Adult, Older Adult) | NCT00114530 | DAIT SCSSc-01 SCOT |
June 2005 | April 2016 | April 2016 | June 16, 2005 | January 29, 2018 | July 14, 2017 |
|
||
21 | NCT02249676 | Completed | Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
15 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02249676 | IRB2013-055-02 | January 2013 | December 31, 2014 | December 31, 2014 | September 25, 2014 | October 17, 2018 |
|
|||
22 | NCT01350219 | Recruiting | Stem Cell Educator Therapy in Type 1 Diabetes |
|
|
Interventional |
Phase 2 |
|
Industry / Other |
|
|
100 | All | 14 Years to 60 Years (Child, Adult) | NCT01350219 | 2010-037 | September 2010 | September 2019 | September 2019 | May 9, 2011 | February 5, 2019 |
|
|||
23 | NCT02741362 | Terminated | Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
2 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT02741362 | ICMS-2015-51 | December 2015 | December 31, 2016 | December 31, 2016 | April 18, 2016 | March 3, 2017 |
|
|||
24 | NCT02674217 | Enrolling by invitation | Outpatient Hematopoietic Grafting in Multiple Sclerosis Employing Autologous Peripheral Blood Stem Cells |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
1000 | All | Child, Adult, Older Adult | NCT02674217 | CentroHMI U1111-1195-1632 |
May 2015 | December 2020 | December 2020 | February 4, 2016 | January 31, 2019 | ||||
25 | NCT02225795 | Withdrawn | Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease. |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
0 | All | 10 Years to 30 Years (Child, Adult) | NCT02225795 | BMT 12 | August 2014 | August 2019 | December 2019 | August 26, 2014 | February 7, 2018 | ||||
26 | NCT01873625 | Completed | Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Affected Knee Osteoarthritis by Rheumatoid Arthritis |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
60 | All | 10 Years to 65 Years (Child, Adult, Older Adult) | NCT01873625 | Royan-RA-001 | October 2009 | March 2011 | December 2011 | June 10, 2013 | June 10, 2013 |
|
|||
27 | NCT01730547 | Unknown † | Mesenchymal Stem Cells for Multiple Sclerosis |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
15 | All | 18 Years to 50 Years (Adult) | NCT01730547 | MSC-MS | February 2013 | December 2015 | December 2015 | November 21, 2012 | January 15, 2015 |
|
|||
28 | NCT00424489 | Terminated Has Results |
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
9 | All | 15 Years to 65 Years (Child, Adult, Older Adult) | NCT00424489 | Myasthenia Gravis Auto 2002 | February 2002 | June 2016 | June 2016 | January 19, 2007 | August 31, 2018 | August 6, 2018 |
|
||
29 | NCT01362179 | Active, not recruiting | National Marrow Donor Program Long-Term Donor Follow-Up |
|
Observational |
|
Other |
|
|
21932 | All | 18 Years to 60 Years (Adult) | NCT01362179 | LTDFU | LTDFU | October 2010 | September 30, 2020 | September 30, 2020 | May 30, 2011 | August 23, 2018 |
|
||||
30 | NCT00076752 | Completed Has Results |
Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus |
|
|
Interventional |
Phase 2 |
|
NIH |
|
|
9 | All | 15 Years to 40 Years (Child, Adult) | NCT00076752 | 040095 04-C-0095 |
January 30, 2004 | October 15, 2013 | October 15, 2013 | February 3, 2004 | May 2, 2017 | June 10, 2014 |
|
||
31 | NCT01378182 | Completed | Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
10 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01378182 | 110S153 | April 2011 | March 2013 | December 2014 | June 22, 2011 | December 31, 2014 |
|
|||
32 | NCT02972801 | Recruiting | Testicular Tissue Cryopreservation for Fertility Preservation |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
250 | Male | Child, Adult, Older Adult | NCT02972801 | PRO09120485 | January 2010 | January 2021 | January 2021 | November 23, 2016 | January 3, 2019 |
|
|||
33 | NCT01297972 | Completed | Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
9 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01297972 | CONEP 16119 | February 2011 | November 2013 | November 2013 | February 17, 2011 | February 4, 2014 |
|
|||
34 | NCT01339455 | Terminated | Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
3 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01339455 | CHREB ID# 23282 | SCT-NMO | March 2011 | March 2017 | March 2017 | April 20, 2011 | May 2, 2018 |
|
||
35 | NCT01056471 | Completed | Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT01056471 | CMM/EM/2008 | January 2010 | June 2012 | June 2015 | January 26, 2010 | August 7, 2015 |
|
|||
36 | NCT03182426 | Recruiting | Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM) |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
60 | All | 18 Years to 45 Years (Adult) | NCT03182426 | Pro00053082 | August 15, 2017 | August 30, 2022 | December 31, 2022 | June 9, 2017 | July 24, 2018 |
|
|||
37 | NCT00684255 | Terminated Has Results |
Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc) |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
1 | All | 7 Years to 50 Years (Child, Adult) | NCT00684255 | AAAB1324 CHNY-01-511 |
August 2007 | July 2008 | July 2008 | May 26, 2008 | April 1, 2014 | December 2, 2009 |
|
||
38 | NCT02676622 | Withdrawn | Autologous Stem Cell Transplant for Refractory Crohn's Disease |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
0 | All | 12 Years to 29 Years (Child, Adult) | NCT02676622 | IRB1100448 | April 2013 | April 2013 | April 2013 | February 8, 2016 | February 3, 2017 | ||||
39 | NCT01668576 | Terminated | Properties of Mesenchymal Stem Cells in Lung Transplant |
|
Observational |
|
Other |
|
|
4 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01668576 | IRB00053075 | August 2012 | September 2014 | September 2014 | August 20, 2012 | January 14, 2016 |
|
|||||
40 | NCT03673748 | Not yet recruiting | Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells |
|
|
Interventional |
Phase 2 |
|
Industry / Other |
|
|
36 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03673748 | TerCel_006 2017-000391-28 |
MSV_LE | January 2019 | December 2021 | December 2021 | September 17, 2018 | September 17, 2018 |
|
||
41 | NCT02035514 | Completed | Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
9 | All | 18 Years to 50 Years (Adult) | NCT02035514 | CELLTRiMS 2010-024081-21 |
December 2013 | July 2016 | July 2016 | January 14, 2014 | December 15, 2016 |
|
|||
42 | NCT00315133 | Completed | Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / Industry |
|
|
25 | All | 12 Years to 35 Years (Child, Adult) | NCT00315133 | HCFMRPUSP | December 2003 | December 2010 | December 2014 | April 17, 2006 | January 18, 2017 |
|
|||
43 | NCT01540175 | Completed | Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant |
|
|
Observational |
|
Other |
|
|
31 | All | up to 21 Years (Child, Adult) | NCT01540175 | XPD12-013 IROPAST | IROPAST | March 2012 | June 2015 | June 2015 | February 28, 2012 | July 14, 2015 |
|
|||
44 | NCT00807651 | Unknown † | Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
40 | All | 14 Years to 35 Years (Child, Adult) | NCT00807651 | CCEMD006 | February 2008 | June 2016 | December 2016 | December 12, 2008 | June 7, 2016 |
|
|||
45 | NCT00230035 | Withdrawn | Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) |
|
|
Interventional |
Phase 2 |
|
NIH |
|
|
0 | All | 18 Years to 60 Years (Adult) | NCT00230035 | DAIT SCSLE-01 | September 2005 | September 30, 2005 | February 1, 2013 |
|
|||||
46 | NCT00957736 | Terminated | Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant |
|
|
Observational |
|
Other / NIH |
|
|
252 | All | Child, Adult, Older Adult | NCT00957736 | VICC BMT 0867 P30CA068485 VU-VICC-BMT-0867 IRB# 080995 |
November 2008 | December 2008 | December 2008 | August 12, 2009 | May 14, 2013 |
|
||||
47 | NCT00278642 | Terminated | Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
1 | All | 18 Years to 60 Years (Adult) | NCT00278642 | DIAD Derm.Auto2001 | September 2002 | September 2011 | September 2011 | January 18, 2006 | April 8, 2013 |
|
|||
48 | NCT01895439 | Completed | Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
13 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01895439 | MSUJCTC | October 2012 | February 2016 | February 2016 | July 10, 2013 | May 2, 2017 |
|
|||
49 | NCT01690247 | Unknown † | Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
50 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01690247 | Beijing302-008 | February 2012 | February 2014 | February 2015 | September 21, 2012 | May 31, 2013 |
|
|||
50 | NCT03326505 | Recruiting | Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
60 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03326505 | ALLOMSUJCTC | September 25, 2017 | May 2019 | May 2020 | October 31, 2017 | October 31, 2017 |
|
|||
51 | NCT01453764 | Withdrawn | Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
0 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT01453764 | AD-US-MS-001 | April 2016 | December 2018 | April 2019 | October 18, 2011 | September 1, 2017 |
|
|||
52 | NCT01661842 | Unknown † | Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
100 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01661842 | Beijing302-006 | October 2011 | October 2014 | October 2014 | August 10, 2012 | May 31, 2013 |
|
|||
53 | NCT01445821 | Recruiting | Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
160 | All | 17 Years to 60 Years (Child, Adult) | NCT01445821 | ASSIST IIb | DIScl2011 | September 2011 | December 2018 | September 2019 | October 4, 2011 | March 29, 2018 |
|
||
54 | NCT02975960 | Completed | ADMSCs for the Treatment of Systemic Sclerosis |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
7 | All | 18 Years and older (Adult, Older Adult) | NCT02975960 | KC16TISI0343 | October 25, 2016 | October 30, 2017 | January 20, 2018 | November 29, 2016 | January 25, 2018 |
|
|||
55 | NCT02274662 | Available | Expanded Access Protocol Thymus Transplantation |
|
|
Expanded Access |
|
Other / Industry | All | Child, Adult, Older Adult | NCT02274662 | Pro00051692 | October 24, 2014 | January 16, 2019 | |||||||||||
56 | NCT00028236 | Completed | Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) |
|
|
Interventional |
Phase 1 |
|
NIH |
|
3 | All | 18 Months to 20 Years (Child, Adult) | NCT00028236 | 020057 02-I-0057 |
December 10, 2001 | July 25, 2011 | July 25, 2011 | December 18, 2001 | July 2, 2017 |
|
||||
57 | NCT02549586 | Active, not recruiting | Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
10 | All | 18 Years and older (Adult, Older Adult) | NCT02549586 | Tol 001 | ASCOTT | December 2015 | December 2018 | January 2020 | September 15, 2015 | May 15, 2018 |
|
||
58 | NCT01662973 | Unknown † | Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
100 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01662973 | Beijing302-005 | October 2011 | October 2013 | October 2013 | August 13, 2012 | May 31, 2013 |
|
|||
59 | NCT03171194 | Active, not recruiting | Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
6 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03171194 | 00061632 | April 27, 2017 | April 2019 | April 2020 | May 31, 2017 | May 10, 2018 |
|
|||
60 | NCT00472225 | Unknown † | Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
|
42 | All | 3 Years to 74 Years (Child, Adult, Older Adult) | NCT00472225 | KHSCT-01-2007 | May 2007 | May 2008 | May 2009 | May 11, 2007 | February 24, 2009 |
|
|||
61 | NCT03297177 | Not yet recruiting | Autologous Stem/Stromal Cells in Neurological Disorders and Disease |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
300 | All | 18 Years to 90 Years (Adult, Older Adult) | NCT03297177 | GARM NDD | NDD | January 1, 2020 | January 1, 2023 | January 1, 2023 | September 29, 2017 | October 18, 2018 |
|
||
62 | NCT00787722 | Active, not recruiting | Hematopoietic Stem Cell Transplant in Devic's Disease |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
13 | All | 16 Years to 65 Years (Child, Adult, Older Adult) | NCT00787722 | DIAD Devic's Disease Auto 2008 | October 10, 2009 | August 2018 | January 2019 | November 7, 2008 | July 17, 2018 |
|
|||
63 | NCT03562065 | Not yet recruiting | Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
10 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT03562065 | P150302 | MSC-SLE | July 1, 2018 | June 1, 2021 | June 1, 2021 | June 19, 2018 | June 19, 2018 |
|
||
64 | NCT03829566 | Recruiting New |
Autologous Transplant To End NMO Spectrum Disorder |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
50 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03829566 | DIAD.ATTEND.2018 | ATTEND | March 2019 | January 1, 2025 | January 1, 2026 | February 4, 2019 | February 4, 2019 |
|
||
65 | NCT00342134 | Completed | Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis |
|
|
Interventional |
Phase 2 |
|
NIH |
|
34 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT00342134 | 999902196 02-N-N196 |
May 1, 2002 | May 4, 2011 | May 4, 2011 | June 21, 2006 | July 2, 2017 |
|
||||
66 | NCT00001630 | Completed | Treatment of Autoimmune Thrombocytopenia (AITP) |
|
|
Interventional |
Phase 1 |
|
NIH |
|
29 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00001630 | 970154 97-H-0154 |
July 21, 1997 | June 11, 2009 | November 4, 1999 | July 2, 2017 |
|
|||||
67 | NCT01953523 | Completed | Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
3000 | All | 16 Years and older (Child, Adult, Older Adult) | NCT01953523 | CSN111 | September 2, 2013 | December 31, 2016 | January 1, 2017 | October 1, 2013 | September 25, 2018 |
|
|||
68 | NCT01347346 | Completed | Gene Therapy for WAS |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
5 | Male | Child, Adult, Older Adult | NCT01347346 | GTG003.08 2009-011152-22 |
May 2011 | January 13, 2016 | January 9, 2017 | May 4, 2011 | May 22, 2018 |
|
|||
69 | NCT01347242 | Recruiting | Gene Therapy for Wiskott-Aldrich Syndrome (WAS) |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
5 | Male | Child, Adult, Older Adult | NCT01347242 | GTG002.07 | March 2011 | December 2019 | December 2019 | May 4, 2011 | May 21, 2018 |
|
|||
70 | NCT00278590 | Withdrawn | Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
0 | All | 18 Years to 50 Years (Adult) | NCT00278590 | DI SLE.Allo2004 | July 2004 | July 2015 | July 2015 | January 18, 2006 | January 13, 2017 |
|
|||
71 | NCT01519141 | Active, not recruiting | Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection |
|
Observational |
|
Other / NIH |
|
|
400 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01519141 | R01HL095130 5R01HL095130 |
July 2003 | June 2019 | June 2020 | January 26, 2012 | December 12, 2018 |
|
|||||
72 | NCT00278486 | Terminated | Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON) |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
2 | All | 18 Years to 60 Years (Adult) | NCT00278486 | DI ARRON 04 | August 2004 | April 2012 | April 2012 | January 18, 2006 | April 8, 2013 |
|
|||
73 | NCT02633163 | Recruiting | Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE) |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
81 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02633163 | MUSC-UCMSC-001 | October 26, 2018 | June 2021 | June 2021 | December 17, 2015 | February 5, 2019 |
|
|||
74 | NCT03219801 | Not yet recruiting | Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Systemic Lupus Erythematosus |
|
|
Interventional |
Early Phase 1 |
|
Other |
|
|
10 | All | 14 Years to 60 Years (Child, Adult) | NCT03219801 | 17277787D-SLE | August 1, 2017 | December 30, 2018 | December 30, 2019 | July 18, 2017 | July 18, 2017 |
|
|||
75 | NCT01415726 | Completed | Stem Cell Educator Therapy in Type 2 Diabetes |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
25 | All | 14 Years to 65 Years (Child, Adult, Older Adult) | NCT01415726 | 2011-010 | July 2011 | February 2012 | February 2012 | August 12, 2011 | February 17, 2012 |
|
|||
76 | NCT01836289 | Withdrawn | High-dose Cyclophosphamide for Severe Refractory Crohn Disease |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
0 | All | 18 Years to 100 Years (Adult, Older Adult) | NCT01836289 | NA_00052668 | March 2015 | March 2018 | March 2018 | April 19, 2013 | August 13, 2018 | ||||
77 | NCT00750971 | Recruiting | Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST) |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
30 | All | 18 Years to 60 Years (Adult) | NCT00750971 | CT-1306 | ASSIST | August 2008 | July 2020 | August 2020 | September 11, 2008 | March 20, 2017 |
|
||
78 | NCT03292263 | Recruiting | ASCT With Nivolumab in Patients With Multiple Myeloma |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT03292263 | 11/17-n | April 24, 2017 | April 2019 | April 2021 | September 25, 2017 | September 25, 2017 |
|
|||
79 | NCT01161628 | Completed Has Results |
Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD) |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
25 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01161628 | NSH 893 | April 2011 | January 2014 | July 2015 | July 13, 2010 | April 20, 2016 | February 24, 2016 |
|
||
80 | NCT00092235 | Recruiting | Factors Determining Outcomes in Patients With Graft-Versus-Host Disease |
|
Observational |
|
NIH |
|
|
550 | All | 1 Year to 75 Years (Child, Adult, Older Adult) | NCT00092235 | 040281 04-C-0281 |
September 20, 2004 | September 22, 2004 | February 15, 2019 |
|
|||||||
81 | NCT00271934 | Completed | Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
52 | All | up to 60 Years (Child, Adult) | NCT00271934 | NU95LU1 | September 2002 | November 2007 | April 2012 | January 4, 2006 | April 11, 2012 |
|
|||
82 | NCT01394640 | Completed | Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients |
|
|
Observational |
|
Other |
|
|
124 | All | 18 Years and older (Adult, Older Adult) | NCT01394640 | INT 72/09 | October 2009 | May 2010 | January 2011 | July 14, 2011 | August 1, 2011 |
|
||||
83 | NCT03602599 | Recruiting | Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls |
|
Observational |
|
NIH |
|
|
500 | All | 18 Years to 100 Years (Adult, Older Adult) | NCT03602599 | 180121 18-D-0121 |
November 15, 2018 | May 31, 2023 | May 31, 2023 | July 27, 2018 | November 20, 2018 |
|
|||||
84 | NCT02835547 | Completed | Evaluation and Management of Cardiovascular Risk Factors in Inflammatory and Acquired Dysimmune Diseases (CARMIN) |
|
|
Observational |
|
Other |
|
|
600 | All | 18 Years and older (Adult, Older Adult) | NCT02835547 | D50841 | CARMIN | February 2009 | August 2015 | August 2015 | July 18, 2016 | July 18, 2016 | ||||
85 | NCT00698191 | Unknown † | Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE) |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
20 | All | 15 Years to 70 Years (Child, Adult, Older Adult) | NCT00698191 | NSFC30772014 | March 2007 | December 2011 | December 2012 | June 17, 2008 | June 17, 2008 |
|
|||
86 | NCT02000362 | Unknown † | Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD) |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
24 | All | 19 Years to 70 Years (Adult, Older Adult) | NCT02000362 | KSTHD_FURESTEM-CD | August 2014 | September 2018 | October 2018 | December 4, 2013 | September 6, 2017 |
|
|||
87 | NCT00278616 | Withdrawn | Hematopoietic Stem Cell Transplantation in Patients With Antiphospholipid Syndrome |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
0 | All | 18 Years to 55 Years (Adult) | NCT00278616 | NU APS AUTO 2004 | August 2005 | October 2011 | October 2011 | January 18, 2006 | April 11, 2012 |
|
|||
88 | NCT02495766 | Active, not recruiting | Autologous Mesenchymal Stromal Cells for Multiple Sclerosis |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
8 | All | 18 Years to 60 Years (Adult) | NCT02495766 | XCEL-MS-02 | EMMES | May 11, 2015 | November 27, 2017 | June 2020 | July 13, 2015 | July 3, 2018 |
|
||
89 | NCT01377870 | Completed | Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
22 | All | 18 Years to 55 Years (Adult) | NCT01377870 | Royn-nerve-001 | December 2011 | March 2014 | April 2014 | June 21, 2011 | March 7, 2018 |
|
|||
90 | NCT00325741 | Unknown † | Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus |
|
|
Interventional |
Phase 1 |
|
NIH / Other |
|
|
15 | All | 18 Years to 64 Years (Adult) | NCT00325741 | 368 P01HL075462-02 |
June 2004 | July 2010 | July 2010 | May 15, 2006 | August 7, 2009 |
|
|||
91 | NCT00920218 | Completed Has Results |
Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
121 | All | 18 Years and older (Adult, Older Adult) | NCT00920218 | 110258 | July 14, 2009 | April 26, 2011 | March 21, 2012 | June 15, 2009 | December 12, 2017 | December 12, 2017 |
|
||
92 | NCT00501995 | Completed Has Results |
High Dose Cyclophosphamide for Treatment of Scleroderma |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
6 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT00501995 | 00-11-17-02 | February 2001 | July 2008 | May 2010 | July 17, 2007 | June 14, 2017 | July 2, 2014 | |||
93 | NCT01741857 | Unknown † | Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
40 | All | 15 Years to 60 Years (Child, Adult) | NCT01741857 | NJGLYY005 | January 2012 | December 2013 | December 2013 | December 5, 2012 | November 5, 2013 |
|
|||
94 | NCT02851056 | Suspended | Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT) |
|
|
Interventional |
Early Phase 1 |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT02851056 | MCC-18346 | August 26, 2016 | September 2019 | September 2020 | August 1, 2016 | January 4, 2019 |
|
|||
95 | NCT01964625 | Terminated | Positron Emission Tomography - Computed Tomography (PET-CT) Scanning in Chronic Graft Versus Host Disease (cGvHD) |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
1 | All | 18 Years and older (Adult, Older Adult) | NCT01964625 | 32186 | November 2010 | August 2013 | August 2013 | October 17, 2013 | October 17, 2013 |
|
|||
96 | NCT03593902 | Recruiting | Cardiac Safe Transplants for Systemic Sclerosis |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
50 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03593902 | DIAD.CAST.2018 | CAST | September 7, 2018 | January 2025 | January 2026 | July 20, 2018 | September 12, 2018 |
|
||
97 | NCT01036958 | Completed | Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host Disease |
|
Observational |
|
NIH |
|
|
3 | All | 5 Years to 18 Years (Child, Adult) | NCT01036958 | 100019 10-C-0019 |
November 25, 2009 | February 6, 2018 | December 21, 2009 | September 26, 2018 |
|
||||||
98 | NCT00989547 | Unknown † | Cord Blood Infusion for Type 1 Diabetes Mellitus (T1DM) |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
18 | All | 1 Year and older (Child, Adult, Older Adult) | NCT00989547 | 593 | September 2008 | September 2014 | October 5, 2009 | July 23, 2013 |
|
||||
99 | NCT03390231 | Recruiting | Stem Cell Educator Therapy in Diabetes |
|
|
Interventional |
Phase 2 |
|
Industry / Other |
|
|
100 | All | 20 Years to 60 Years (Adult) | NCT03390231 | S2017-059-01 | November 27, 2017 | December 30, 2020 | December 31, 2020 | January 4, 2018 | February 5, 2019 |
|
|||
100 | NCT03421548 | Withdrawn | Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1 |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
0 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT03421548 | 2016-6261 | BKPro | November 2016 | January 2020 | June 2020 | February 5, 2018 | February 5, 2018 |
† Study has passed its completion date and status has not been verified in more than two years.